Newsletters
DTN 130: China's Biotech Industry on the Rise
Plus: DIY drones flood the skies, the end of Natcast, Christie's deletes NFT department, self-assembling silicon nanowires, exotic phase of matter on a quantum processor, and more.
Newsletters
Plus: DIY drones flood the skies, the end of Natcast, Christie's deletes NFT department, self-assembling silicon nanowires, exotic phase of matter on a quantum processor, and more.
Conversations
Nobuhiro Seki is a managing partner at Monozukuri Ventures, a venture capital firm that connects deep tech startups with Japan’s manufacturing ecosystem.
Conversations
Abe Murray is a general partner at AlleyCorp, an early-stage venture fund that invests across deep tech, healthcare, enterprise software, and consumer tech.
Newsletters
Plus: lunar soil bricks, wifi signals measure heart rate, robots walk on water, SpaceX cleared to double Florida launches, Pentagon considers AI-generated propaganda, Taco Bell rethinks AI drive-through, and more.
Conversations
James Barlia is the Executive Director of Station DC, a non-profit connecting innovators, policymakers, and industry leaders in Washington, D.C.
Conversations
Michael Dempsey is a managing partner at Compound, a thesis-driven research-centric venture capital firm investing in deeply technical and scientific areas.
Newsletters
Plus: Martian metals, Starship success, China's growing brain-computer interface industry, AI-simulated disasters, oxygen made in space, transplanting pig lungs, and more.
The most widely read newsletter in deep tech. Get exclusive interviews, deals, and news from the frontier in your inbox. Every Friday.
Plus: Avalanche's desktop fusion reactor, NASA's X-59 goes supersonic, NY lawmakers pass first in US data center moratorium, China's big bet on big nuclear reactors, and more.
Viktor Shpakovsky is an investment partner at Beyond Earth Ventures, a $30 million venture capital fund investing in transformative deep tech across space tech, robotics, energy, and compute.
Plus: Agtech investment is booming, SpaceX outlines plans for Starfall re-entry vehicles, AI executives call for stricter regulations on synthetic biology, the people who want AI to replace humanity, and more.
Brian Wilcove is the managing director of America's Frontier Fund (AFF), a sovereign-aligned venture capital firm investing in frontier technologies to strengthen U.S. innovation and economic competitiveness.
Plus: Blue Origin's mega-rocket explodes, race to mine the deep sea, IBM's first pure-play quantum chip foundry, NASA selects companies for moon base awards, and more.
Plus: Biomanufacturing to reshape organ transplants, grid batteries are booming, quantum's make-or-break moment, growing chickens in 3D printed eggs, Japan sells out of robot wolves, in-space refueling demo, and more.
Plus: Helium-3 lunar gold rush, Virgin Galactic to begin commercial service, Cowboy files for 20k orbital data centers, non-viral gene therapy, real life gundams, and more.
Plus: China opens rocket launches to international satellites, the future of IVF, a geothermal IPO, big tech targets drug discovery, DARPA eyes commercial space boom, and more.
Plus: Pentagon's drone spending spree, air taxis come to NYC, Zuck's virtual biology initiative, DeepSeek's new model, FDA wants to accelerate clinical trails with AI, and more.
Plus: New Glenn suffers upper stage malfunction, China ramps up satellite capacity, cracks in fusion's funding boom, robot marathon, slime-like artificial muscles, cocaine-fueled salmon, and more.
Paul Veugen is co-founder and partner at NP-Hard Ventures, an Amsterdam-based early-stage venture capital firm investing in pre-seed and seed companies solving the hardest problems across robotics, defense tech, and foundational infrastructure.
Plus: nuclear reactors on the moon, implantable pharmacies, 3D printing batteries, first complete human genome loaded onto quantum computer, Science Corp gets ready for brain implant, ARPA-E doubles down on fusion, and more.